THE JAK2V617F POINT MUTATION INCREASES THE OSTEOCLAST FORMING ABILITY OF MONOCYTES IN PATIENTS WITH CHRONIC MYELOPROLIFERATIVE NEOPLASMS AND MAKES THEIR OSTEOCLASTS MORE SUSCEPTIBLE TO JAK2 INHIBITIONEmmanouil Spanoudakis, Ιoannis Kotsianidis, Ioanna Bazntiara et al.|Mediterranean Journal of Hematology and Infectious Diseases|2018Cited by 9